4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide-D3; 4-(5-Methyl-d3-3-phenyl-4-isoxazolyl)benzenesulfonamide; Bextra-d3; SC 65872-d3; Valecoxib-d3; Valus-d3; Valz-d3;
Valdecoxib-d3 is a fully characterized chemical compound used as a reference standard of API Valdecoxib. The standard offered is compliant with regulatory guidelines. Valdecoxib-d3 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1219794-90-7
Related products
3-Phenyl-4-(4-aminosulfonylbenzyl)-5-methylisoxazole
M.F.
M.W. 328.39
CAT# AR-V01023
CAS# 1391052-01-9
